A Twin Cities startup that aims to fight bacterial infections with human stool is seeking $25 million in capital, according to a regulatory filing.
Roseville-based Rebiotix targets patients who suffer from C. difficile, a bacterial infection that’s typically acquired during hospital stays. Research dating back as far as the 1950s has shown that transplanting “good” bacteria from a healthy person’s stool into a sick patient is an effective treatment.
Help employers find you! Check out all the jobs and post your resume.
